BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crawt L, Atkinson E, Tedcastle A, Pegg E, Dobly A, Wei C, Lei S, Ling P, Li C, Zheng J, Wang Y, Liqun H, Jorajuria S, Cozic G, Ugiyadi D, Kurniati N, Ochiai S, Miyazawa M, Someya Y, Nishihama T, Masafumi M, Westdijk J, Crowe S, Graaf MD, Kouiavskaia D, Chumakov K, Minor P, Cooper G, Rigsby P, Martin J; sIPV Study Group. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays. The Journal of Infectious Diseases 2019. [DOI: 10.1093/infdis/jiz076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Murakami K, Fujii Y, Someya Y. Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats. Vaccine 2020;38:3295-9. [PMID: 32197923 DOI: 10.1016/j.vaccine.2020.03.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Abd-Elghaffar AA, Rashed ME, Ali AE, Amin MA. In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine. Vaccines (Basel) 2020;8:E601. [PMID: 33066050 DOI: 10.3390/vaccines8040601] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kouiavskaia D, Puligedda RD, Dessain SK, Chumakov K. Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines. J Virol Methods 2020;276:113785. [PMID: 31765719 DOI: 10.1016/j.jviromet.2019.113785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi L, Sun M. The progress of postapproval clinical studies on Sabin IPV. Hum Vaccin Immunother 2021;:1-4. [PMID: 34213408 DOI: 10.1080/21645515.2021.1940653] [Reference Citation Analysis]
5 Cai W, Ping L, Shen W, Liu J, Zhang M, Zhou J, Peng J, Wang M, Zhu Y, Ji G, Wang X, Ji Q, Lai C, Shi L, Che Y, Sun M. Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains. Hum Vaccin Immunother 2020;16:1866-74. [PMID: 32118517 DOI: 10.1080/21645515.2019.1709352] [Reference Citation Analysis]
6 Cramer JP, Jimeno J, Han HH, Lin S, Hartmann K, Borkowski A, Sáez-Llorens X. Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial. Vaccine 2020;38:5313-23. [PMID: 32563609 DOI: 10.1016/j.vaccine.2020.05.081] [Reference Citation Analysis]